Arkolith/Insider Trading/HUMA/Form 4

Sebelius Kathleen

DirectorHumacyte, Inc. (HUMA) · full profile →Form 4 · filed Jun 17, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 14, 2024Option exercise(M)39K$2.56$101K39K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 14, 2024Option exercise(M)39K—$00
Jun 13, 2024Grant(A)50K—$050K

Transaction Codes

M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001818382-24-000143) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML